Masimo Corporation (MASI): Price and Financial Metrics


Masimo Corporation (MASI)

Today's Latest Price: $261.37 USD

0.39 (-0.15%)

Updated Jan 15 4:00pm

Add MASI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 185 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MASI Stock Summary

  • With a one year PEG ratio of 404.79, Masimo Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.87% of US stocks.
  • Price to trailing twelve month operating cash flow for MASI is currently 66.48, higher than 92.88% of US stocks with positive operating cash flow.
  • For MASI, its debt to operating expenses ratio is greater than that reported by only 0.53% of US equities we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Masimo Corp are TECH, ABMD, LOGI, DLB, and CGNX.
  • Visit MASI's SEC page to see the company's official filings. To visit the company's web site, go to www.masimo.com.

MASI Stock Price Chart Interactive Chart >

Price chart for MASI

MASI Price/Volume Stats

Current price $261.37 52-week high $284.86
Prev. close $261.76 52-week low $143.90
Day low $260.58 Volume 277,400
Day high $266.60 Avg. volume 271,340
50-day MA $260.24 Dividend yield N/A
200-day MA $233.43 Market Cap 14.39B

Masimo Corporation (MASI) Company Bio


Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company was founded in 1989 and is based in Irvine, California.


MASI Latest News Stream


Event/Time News Detail
Loading, please wait...

MASI Latest Social Stream


Loading social stream, please wait...

View Full MASI Social Stream

Latest MASI News From Around the Web

Below are the latest news stories about Masimo Corp that investors may wish to consider to help them evaluate MASI as an investment opportunity.

Respiratory Monitoring Equipment Market 2020 -2026 Impact of Worldwide Growth and Forecast Analysis | Medtronic, Philips Healthcare, Smiths Medical, GE Healthcare, Welch Allyn, Masimo, MGC Diagnostics Corporation, Vyaire Medical and Nihon Kohden Corporati

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Respiratory Monitoring Equipment Market Research Report 2020”. The Global Respiratory Monitoring Equipment Market Report 2020 is a professional and in-depth study on the current state of the

OpenPR | January 16, 2021

How Covid-19 Impact on Wearable Patient Monitor Market Growth Analysis and Forecast 2026 | Medtronic, Philip, Apple, BioBeat Technologies, Equivital, Vital Connect, iRhythm Technologies, Caretaker Medical, Masimo, Biopac Systems, Thought Technology, Healt

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Wearable Patient Monitor Market Research Report 2020”. The Global Wearable Patient Monitor Market Report 2020 is a professional and in-depth study on the current state of the

OpenPR | January 16, 2021

Masimo (MASI) Reports Encouraging 2020 Preliminary Results

Per the preliminary announcement, Masimo (MASI) projects 2020 product revenues to improve.

Yahoo | January 15, 2021

Masimo’s 2021 Profit Outlook Misses Analysts’ Estimates

Masimo Corp. provided lower-than-projected profit guidance for 2021, while the medical instruments manufacturer expects adjusted earnings for last year to exceed the initial forecast of $3.46 per share. Masimo (MASI) is scheduled to report its 2020 financial results on Feb. 23. Analysts expect the company to report adjusted earnings of $3.49 per share in 2020. Further, the company forecasted to generate product revenues in the range of $1.139 billion to $1.144 billion, representing year-over-year growth of 21.6% to 22.2%. The company expects shipments of noninvasive technology boards and instruments of about 472,000 in 2020. As for 2021, the company sees adjusted earnings of $3.

Amit Singh on TipRanks | January 14, 2021

Masimo Co. (NASDAQ:MASI) Director Craig B. Reynolds Sells 10,000 Shares of Stock

Masimo Co. (NASDAQ:MASI) Director Craig B. Reynolds sold 10,000 shares of Masimo stock in a transaction that occurred on Monday, January 11th. The stock was sold at an average price of $279.74, for a total transaction of $2,797,400.00. Following the completion of the transaction, the director now owns 14,300 shares in the company, valued at […]

Watchlist News | January 14, 2021

Read More 'MASI' Stories Here

MASI Price Returns

1-mo -1.61%
3-mo 10.87%
6-mo 6.57%
1-year 53.98%
3-year 202.86%
5-year 606.98%
YTD -2.61%
2020 69.80%
2019 47.21%
2018 26.62%
2017 25.82%
2016 62.37%

Continue Researching MASI

Want to see what other sources are saying about Masimo Corp's financials and stock price? Try the links below:

Masimo Corp (MASI) Stock Price | Nasdaq
Masimo Corp (MASI) Stock Quote, History and News - Yahoo Finance
Masimo Corp (MASI) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8816 seconds.